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Abstract. The complete primary structure of the core
protein of rat NG2, a large, chondroitin sulfate proteo-
glycan expressed on 02A progenitor cells, has been
determined from cDNA clones. These cDNAs hybridize
to an mRNA species of 8.9 kbp from rat neural cell
lines. The total contiguous cDNA spans 8,071 nucleo-
tides and contains an open reading frame for 2,325
amino acids. The predicted protein is an integral mem-
brane protein with a large extracellular domain (2,224
amino acids), a single transmembrane domain (25 amino
acids), and a short cytoplasmic tail (76 amino acids).
Based on the deduced amino acid sequence and immu-
nochemical analysis of proteolytic fragments of NG2,
P
ROTEOGLYCANs are a group ofmolecules that contain
glycosaminoglycan chains covalently linked to their
core proteins. A large number of these molecules are
found in the extracellular matrix or on the cell surface and
have been implicated in a wide variety ofcell functions, such
as cell adhesion (Yamagata et al., 1989; Stamenovic et al .,
1989), cell-interaction and migration(Rapraegeretal., 1986;
Tan et al., 1987; Perris et al., 1987), and cell proliferation
(Yamaguchi and Ruoslahti, 1988; see Gallagher, 1989 and
Ruoslahti, 1989 for reviews). Some of these functions may
be mediated by the ability of the proteoglycans to intact with
different extracellular matrix molecules and growth factors
(Ruoslahti, 1989; Yamaguchi et al., 1990). Our understand-
ing of the functions of proteoglycans is currently being en-
hanced by the elucidation ofprimary structures for a number
of different proteoglycan core proteins. Such structural anal-
yses have revealed that many proteoglycan core proteins
share similar sequence motifs and can be grouped into sev-
eral families.
We have been studying the structure and expression of a
large, cell surface proteoglycan, NG2, originally found to be
expressed by neural cells (Stallcup, 1981) . NG2 is expressed
on proliferating 02A progenitor cells (gaff et al ., 1983)
obtained from primary cultures of the newborn rat optic
nerve (Stallcup and Beasley, 1987) and cerebellum (Levine
and Stallcup, 1987). Immunohistochemical studies using tis-
sue sections of developing rat embryos have also shown a
widespread distribution of NG2 in the extraneural tissues,
especially in the developing mesenchyme (Nishiyama et al .,
© The Rockefeller University Press, 0021-9525/91/07/359/13 $2.00
The Journal of Cell Biology, Volume 114, Number 2, July 1991 359-371
the extracellular region can be divided into three do-
mains : an amino terminal cysteine-containing domain
which is stabilized by intrachain disulfide bonds, a se-
rine-glycine-containing domain to which chondroitin
sulfate chains are attached, and another cysteine-con-
taining domain. Four internal repeats, each consisting
of 200 amino acids, are found in the extracellular do-
main of NG2. These repeats contain a short sequence
that resembles the putative Ca++-binding region of the
cadherins. The sequence of NG2 does not show signifi-
cant homology with any other known proteins, suggest-
ing that NG2 is a novel species of integral membrane
proteoglycan.
1991). The expression of NG2 seems to be developmentally
regulated in that the level of expressionis highest on imma-
ture, proliferating cellsand decreases as these cells differen-
tiate.
NG2 is expressed abundantly on the surface of a neural
cell line, B49, which was used for most of the biochemical
and inununochemical studies. NG2 is a large chondroitin
sulfate proteoglycan of 400-800 kD with a core protein size
of 300 kD (Stallcup et al ., 1983). Its inextractability in the
absence of detergents is typical of a membrane-intercalated
molecule.
Here we report the complete primary structure of NG2
core protein deduced from the cDNA sequence. The pre-
dicted protein is an integral membrane protein with a large
extracellular domain and a short cytoplasmic tail. Compari-
son of the amino-terminal sequences has shown that human
melanoma proteoglycan (Harper and Reisfeld, 1987) is the
human homologue of NG2 (R. Spiro, Research Institute of
Scripps Clinic, La Jolla, CA, personal communication). The
NG2 sequence has few similarities to other known proteins,
indicating that NG2 is a novel species of integral membrane
proteoglycan .
Materials andMethods
CellLines
The derivation ofrat B49, B82, BI 11, B9, and B28 neural cell lines has been
described (Schubert et al., 1974). PC12 cells are derived from a rat pheo-
chromocytoma (Greene and Tischler, 1976). The cells were maintained in
359MEM with 10% FCS (or 10% horse serum in the case of PC12) and in-
cubated at 37°C in the presence of 10% C02.
Analysis ofPurified NG2
NG2 waspurified fromB49 cells as described by Stallcup etal. (1990). Cy-
anogen bromide (CNBr)' fragments of purified NG2 were generated by
treatment with 4% CNBr in 70% formic acid for 1 h at room temperature.
These peptideswerepurified by preparative acrylamide gel electrophoresis,
followed by recovery from the gel strips using an electroelution chamber
(Isco, Inc., Lincoln, NE). Amino-terminal sequences were obtained from
these peptides and from purified intact NG2 using a protein sequencer
(model470A; Applied Biosystems, Foster City, CA) in conjunction with an
HPLC analyzer (model 120A; Applied Biosystems) .
Antibodies
The derivation and specificity ofrabbitantibodies against intact NG2 (4447,
553) have been described (Levine and Card, 1987; Stallcup et al., 1990).
In addition, we have prepared antisera against several discrete portions of
the NG2 molecule. Rabbit antiserum 1088 was raised against a synthetic
peptide (19 amino acids) derived from the amino-terminal peptide sequence
ofpurified NG2. 1014, 1114, and 1116 are rabbit antisera generated by im-
munizing the rabbits with 95-, 55-, and 35-kD CNBr cleavage products,
respectively. The derivation and specificity ofthe mAbs D31.10, N143, and
N92 have been described (Levine and Card, 1987; Stallcup et al., 1990).
These three mAbs have been found to recognize different epitopes on the
NG2 core protein.
To generate a rabbit antibody against the cytoplasmic region of NG2, a
cDNA fragment encoding the cytoplasmic domain of NG2 (nucleotides
6825-7038) was amplified using the polymerase chain reaction technique
(Saiki et al., 1985) and subcloned into pUR291 (a gift from Dr. D. A.
Laughon, University of Wisconsin, Madison, WI; Carroll and Laughon,
1987) in the appropriate reading frame. ß-galactosidase fusion protein was
induced in the host cells, precipitated with 35% saturated ammonium sul-
fate, and further purified by preparative acrylamide gel electrophoresis. The
eluted protein was used for immunization. This antibody was designated
1466.
cDNA Libraries
Poly (A)+ RNA was isolated from B49 or B82 rat neural cell lines by the
methodofBadley et al . (1988) orby isolatingtotal RNA according to Chirg-
win et al . (1979) followed by oligo (dT) cellulose chromatography as de-
scribed by Aviv and Leder (1972). A Xgtll cDNA library was prepared
commercially with random and oligo (dT)primers (Stratagene Cloning Sys-
tems, La Jolla, CA). Another cDNA library was constructed in XZAP II
(Stratagene Cloning Systems) using both random and oligo (dT) primers by
the method of Gubler and Hoffmann (1983). A primer extended cDNA li-
brary was constructed from B82 poly (A)' RNA in Xgt10 (Stratagene
Cloning Systems) using a synthetic primer derived from the sequence of
clone XNG18 (see Fig. 2). A second primer-extended cDNA library was
constructed from B49 poly (A)
+ RNA in XZAP II with a primer based on
the sequence ofclone 77 (see Fig. 2). Reactions forthe first strand synthesis
were carried out with Moloney murine leukemia virus reverse transcriptase
(BRL, Gaithersburg, MD). The cDNA was cloned into the EcoRI site of
the vectors by using EcoRllinkersor adaptors. Oligonucleotide primers and
EcoRI linkers were synthesized on a DNA synthesizer (model 38013; Ap-
plied Biosystems) .
Isolation ofcDNA Clones
The Xgtll B49 cDNA library was immunoscreened with a mixture of anti-
CNBr fragment polyclonalantibodies, 1014, 1114, and 1116, each at 1:1,000
dilution. Immunoscreening was performed as described by Hunyh et al.
(1985) using HRP-labeled goat anti-rabbit IgG (1:3,000; Bio-Rad, Rich-
mond, CA) as the second antibody.
After the first cDNA clone, XNG18, was isolated by immunoscreening,
subsequent clones were obtained by plaque hybridization using 32p-labeled
cDNA probes. Labeling of cDNA probes for plaque hybridization and
Northernand Southernblotswas doneby the methodofFeinbergandVogel-
stein (1983).
1. Abbreviation used in this paper: CNBr, cyanogen bromide.
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To rule out possible ligation artifacts which might have occurred during
library construction, polymerase chain reaction was performed using B49
cDNA as template to generate a cDNA fragment (G66, see Fig. 2) which
covers the internal EcoRl site at nucleotide 652.
cDNA inserts from Xgtll and Xgt10 clones were purified and subcloned
into Bluescript plasmid vector (Stratagene Cloning Systems). Clones from
XZAP R libraries were excised in vitro using helper phage to obtain inserts
in Bluescript.
DNA Sequence Determination and Analysis
DNA sequencing was performed by the dideoxy chain termination method
(Sanger et al., 1977) using a modified T7 DNA polymerase (Sequenase;
United States Biochemicals Corp., Cleveland, OH). Nucleotide sequence
was determined from restriction fragments subcloned into Bluescript from
nested deletion mutants generated by exonuclease III (Promega Biotec,
Madison, WI) according to the method of Henikoff (1984), or by using oli-
gonucleotide primers synthesized on the basis ofthe preceding sequences.
DNA sequence was determined for both strands throughout the coding re-
gion of NG2.
Editing and analyses of the sequence were done using Genepro (Riv-
erside Scientific Enterprises, Bainbridge Is., WA) and PC Gene (Intelli-
genetics, Mountain View, CA) software. Sequence comparisons with the
databases Genbank (release 66) and Swiss-Prat (release 16) were performed
using the Pearson-Lipman algorithm (Pearson and Lipman, 1988) with a
ktup value of 2.
Immunocytochemistry
For cell surface staining, B49 cells were washed briefly with Hepes buffer
containing 2% calf serum, followed by incubation with primary anti-NG2
antibodies for 30 min at room temperature. After four washes in the same
buffer, the cells were incubated with FITC-conjugated goat anti-rabbit or
goat anti-mouse Ig (1:50 dilution, Tago Inc., Burlingame, CA) for 30min at
room temperature. After threewashes in PBS, the cells were fixed with eth-
anol for 10 min at -20°C, air-dried, and mounted in 90% glycerol in PBS.
For cytoplasmic staining, B49 cells were rinsed with PBS, fixed in 2 %
paraformaldehyde for 10 min at room temperature, washed five times with
PBS for a total of 30 min, and incubatedwith the first and second antibodies
as described above. Triton X-100 was added to 0.1% in the primary anti-
bodies.
Immunoprecipitations
1349 cells were surface labeled with 1211 by the lactoperoxidase method
(Hubband and Cohn, 1972). In somecases, 1% NP-40 extracts ofthese cells
were used for immunoprecipitations. In other cases, we immunoprecipi-
tated fragments ofNG2 released fromthe cell surface by proteolysis to ob-
tain structural information about different portions ofthe molecule. A 120-
kD cryptic fragment was released from the cells by treatment with 5 kglml
of trypsin at room temperature for 30 min. A 200-kD proteolysic fragment
was released by treating labeled cell with 10 mM EDTA at room tempera-
ture for 2 h in the presence ofchondroitinase ABC. In both of these cases
the supernatants were adjusted to 1% NP-40 and 0.5% SDS and used for
immunoprecipitation.
Immunoprecipitationswith avariety ofantibodies were carried outas de-
scribed (Stallcup et al., 1990). The precipitates were dissolved in elec-
trophoresis sample buffer containing 20% glycerol and 3% SDS. To some
samples, 5 % 2-mercaptoethanol was added in order to reduce disulfide
bonds. The samples were electrophoresed through 3-20% polyacrylamide
gradient gels (Laemmli, 1970) using 2.5% stacking gels. Gels were dried
and exposed for autoradiography using Kodak XAR-5 film.
Northern Blot Analysis
RNA was extracted from cultured cells by first isolating total RNA as de-
scribed by Chirgwin et al. (1979). Poly (A)+ RNA was purified by oligo
(dT) cellulose chromatography according to Aviv and Leder (1972). 5 jig
ofpoly (A)+ RNA were electrophoresed through a 1% agarose gel contain-
ing 2.2 M formaldehyde, and transferred to nitrocellulose filters. The filters
were hybridized according to the method ofThomas (1980). An 896-bp in-
sert from XNG18 (see Fig. 2) was labeled with 32P and used as a probe at
a specific activity of 3 x 106 cpm1ml. The filters were washed to a final
stringency of 0.2 x SSC (1 x SSC = 0.15 M NaCl and 0.015 M sodium
citrate) at 60°C and exposed to Kodak XAR5 film for autoradiography.
360Figure 1. Northern blot of poly (A)+ RNA from NG2-positive and
NG2-negative cell lines . 5 jig of poly (A)+ RNA were electropho-
resed through a 1% agarose gel containing 2.2M formaldehyde,
blotted onto a nitrocellulose filter, and hybridized with 32P-labeled
XNG18 insert . The positions of 28S and 18S ribosomal RNA are
indicated on the left . 8.9 kbp NG2 mRNA is detected in the three
NG2-positive cell lines (B49, B82, and B111), but not in theNG2-
negative cell lines (B9, B28, and PC12) .
Southern BlotAnalysis
High molecular weight genomic DNA was isolated from rat liver tissue by
the method of Ellin and Stafford (1976) . 10 ug of the DNA were digested
with BamHI, EcoRl, HindIll, or PstI, electrophoresed through a 0.7%
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agarose gel, and transferred to a nitrocellulose filter as described by South-
ern (1975) . The filter was hybridized with a 32P-labeled probe derived from
a 415-bp Pstl fragment near the carboxy terminus of NG2 (nucleotides
6094-6519 ; Fig . 2, 9P400) . Hybridization, washes, and autoradiography
were done as described above for Northern blot analysis .
Results
Isolation ofcDNA Clones
One positive clone was initially isolated by immunoscreen-
ing Nl x 106 plaques from a commercially prepared B49
Xgtll cDNA library with a mixture of three rabbit antibodies
against differentCNBr cleavage products ofNG2 . This clone
(XNG18) contains an insert of 896 bp. In addition to binding
to the rabbit antibodies, the ß-galactosidase fusion protein
from XNG18 also reacts with the NG2-specific mAb N92 .
The XNG18 insert was labeled and used to probe a Northern
blot that contained poly (A)+ RNA from various cell lines
(Fig . 1) . An mRNA species of 8.9 kbp in size was detected
only in cell lines previously found to be positive for NG2 by
immunofluorescence and immunoprecipitation (B49, B82,
and Blll) . The 8.9-kbp mRNA was absent from the NG2-
negative cell lines, B9, B28, and PC12 . The 8.9-kbp mRNA
is sufficient in size to code for a protein with an approximate
molecular mass of300MThe XNG18 insert was subcloned
into Bluescript for further analysis (pNG18) . The authentic-
ity ofthis clone was unequivocally established by identifica-
tion of a peptide sequence from the 55-kD CNBr fragment
within the deduced amino acid sequence ofpNGl8 (see Fig .
3, long, dashed underline) .
pNG18 insert was 32P labeled and used as a probe to ob-
tain overlappingcDNA clones. After several rounds of screen-
ing usingpNG18 and other probes, overlapping clones cover-
ing the entire coding region ofNG2 were obtained from four
different cDNA libraries . Fig . 2 shows the positions of the
differentcDNA clones used for determining the complete se-
quence of NG2 . Sequence for most areas of the coding re-
gion were derived from at least two independent clones .
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Figure 2. A scheme of overlapping cDNA clones coding for NG2 . A scale in kilobase pairs is shown at the top. The bar in the middle
represents NG2 mRNA, with the thick black bar being the coding region . Location of different clones are shown below along with the
cDNA libraries from which they were obtained . Dotted lines above the black bar represent cDNA fragments used as probes for Northern
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GCT IC11 GCA GAI GGG CCA CCC AGC CTG CAC CCT GTG CAC CGC TTC ICC CAA GAG GCA ATA AAT TCA GGC CGG GYT CTC TAC TIC CAC
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CGC CCT GGA GCC TGG AGI GAI TCC TTC TCC 4080
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Figure 3 . cDNA sequence and the deduced amino acid sequence of rat NG2. Single letter amino acid symbols are used . The putative
transmembrane domain is boldly underlined . Deduced sequences corresponding to known peptide sequences are shown by dashed lines.
Cysteine residues are circled. Potential N-linked glycosylation sites are indicated by asterisks. Potential glycosaminoglycan attachment
sites are underlined . Potential sites in the cytoplasmic domain for phosphorylation by protein kinase C are indicated by arrowheads . These
sequence data are available from EMBL/GenBank/DDBJ under accession number X56541 .
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AM GCT GGA GCC TIC CTC ACC TG CTT AGA CCT AM GAG CCA GG GGG CG AGG TM GAG GCA OCT TM GTC AGC TG CTG CAG AAA ACA GM TM CAT CCT CM TOO ATC ACA ACT CCG
GGT CCT GGC ACT OTC ACC TM CAT ACG TG MC CTG ACT CAG ACT GCC MG GTC GGG AM AU GAG CAC CCT GGG TTT TCC ACC CG GCT CTG GTC ATT TOT TOI CTC TM AGA AG MC
TCT CCC TCC CTG GIG ITT TCC TCA AGC TGA ATG GGG AGO AAT GTT AGO CAA TAG ATT AAT ATA TIC MG GIG CAA GAT GGG TOO GOT TGC TCT GGG GTT GOT TAA ITT AAG GCA AGA MG
CIA ITT AAG ATG GIG CTG GGC TAG CCA GAC CIA ATG MA GCC CTG GAG TAT ATG GM TGG ACA MG GTC tGl( AGC CAT TIC ACC CAC AGA GCC CTG TGC CAG AGC ATG GM ACA TTG ACG
GGC MC CTT GAG CAC TTG SAC TGG GAG CGT TGG AGG CCA GTC TGG TM CG TCC GC7 CCY CAA CAC TAG GM GCG GCT AAA CTG GGG CAC TTG ACT CG TGG ACC CTT AGT GM TGG TGC
TTC AGG GGC TCC GGA CAC CTG TGC ACT GTC TIC TOI TTG ACT CTC CAC TGG GCT CTG ATT CCC TGG CAC CTT TGC TCC CTG GGG GG CTG TOI GGC CTA GCT TCA TGG GGT OGG GAI GM
CM GCT CM MA TTT CG CCT CCT GM CGT TCC CM CAT CCT CTC CTC TG CCT CIG CIO GG GAI GTG iTT GTT GAG ATG GG1 CCA MG CCC TTA CAC TAC AGG GAA CTT CM GGG GGG
AM CAA MT AM MT AAA TGC TCG GG CCA T (POLY A)
Figure 3 .
Sequence Analysis
The complete cDNA sequence of the NG2 core protein and
the deduced amino acid sequence are shown in Fig. 3 . The
clones cover 8,071 nucleotides with an open reading frame
coding for 2,325 amino acids. The calculated molecular
mass is 251,470 D . The 3' untranslated region consists of
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1,027 nucleotides and contains two polyadenylation signals
(AATAAA) 24 and 18 by upstream of the poly (A) tail . In
the coding region, sequences of two of the CNBr cleavage
products can be identified (Fig. 3, long, dashed underlines) .
The amino-terminal amino acid sequence determined from
purified NG2 is also found, beginning at residue 30 (Fig. 3,
short, dashed underline) . This amino terminal sequence ofFigure 4. Immunofluorescence staining of live and permeabilized B49 cells . (a, c, e, g, i, and k) Phase contrast . (b) Live B49 cells stained
with rabbit anti-intact NG2 antibody, 553 (1:1,000) . (d) Live B49 cells stained with monoclonal anti-NG2 antibody D31.10 (ascites fluid,
1:100) . (f) Permeabilized B49 cells stained with prebleed from 1466 rabbit (1:100) . (h) Permeabilized B49 cells stained with rabbit anti-
NG2 cytoplasmic domain antibody, 1466 (1:100) . (j) Live B49 cells stained with prebleed from 1466 rabbit . (1) Live B49 cells stained
with 1466 . Both 553 and D31.10 stain live B49 cells . 1466 stains fixed and permeabilized B49 cells but does not stain live cells. Bar, 100 jm .
NG2 is identical to the amino-terminal sequence determined
for the core protein of human melanoma proteoglycan (R .
Spiro, personal communication ; Harper and Reisfeld, 1987) .
The nucleotide sequence around theATG at position 70 con-
forms to the consensus sequence for the translation initiation
site (Kozak, 1984) . The 5'69 by of the cDNA contribute to
the 5' untranslatedTegion . Between the first methionine and
the beginning of the amino terminal peptide sequence is a
stretch ofhydrophobic amino acids that forms a putative sig-
nal sequence .
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Hydropathy analysis of the predicted protein using the
method of Kyte and Doolittle (1982) reveals a second hydro-
phobic segment near the carboxy terminus containing 25 hy-
drophobic amino acids (residues 2225-2249), followed by
several basic residues (Fig . 3, boldly underlined) . This ar-
rangement meets the criteria for a transmembrane domain
proposed by,Sabatini et al . (1982) . Immunocytochemistry
was performed on live and permeabilized B49 cells to deter-
mine the orientation ofNG2 with respect to the plasmamem-
brane (Fig. 4). . Rabbit antibody raised against purified, intact
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Figure S. (A) A scheme of the primary structure of NG2. Black bar represents the coding region of NG2. (shaded area) Transmembrane
domain. C, cysteine residue. S, serine residue in serine-glycine pair whichmay be a potential glycosaminoglycan attachment site. (*) Poten-
tial N-linked glycosylation site. Scale is shown at the top. (B) Different domains of the NG2 core protein. TM, transmembrane domain.
CP, cytoplasmic domain. (C) Location of the proteolytic fragments and the 55-kD CNBr fragment of NG2.
NG2 (553) stains live B49 cells (Fig. 4 b). mAb D31.10,
which recognizes a fragment of NG2 containing the amino
terminus, also stains live B49 cells(Fig. 4 d), providing evi-
dence that the large amino-terminal segment is located ex-
tracellularly. Antiserum 1466, raised against the predicted
cytoplasmic domain ofNG2, does not stain living cells (Fig.
4 l), but stains B49 cellsafterthey are fixed with 2 % parafor-
maldehyde and permeabilized with 0.1% Triton X-100 (Fig.
4 h) . The prebleed from 1466 rabbit does not show any reac-
tivity on live or permeabilized B49 cells (Fig. 4, j and f) .
This verifies the hypothesis that amino acid residues 2250-
2325 form the cytoplasmic portion of the molecule. Thus,
the deduced amino acid sequence of the NG2 core protein
predicts an integral membrane protein whose transmembrane
domain divides the molecule into a large, amino terminal ec-
todomain and a short cytoplasmic domain at the carboxy ter-
minus. The main features of the primary structure of NG2
are shown schematically in Fig. 5 A .
The cytoplasmic domain consists of 76 amino acids. It
contains three threonine residues whose surrounding amino
acid sequences conform to the motif for protein kinase C
phosphorylation sites (Fig. 3, arrowheads; Kemp and Pear-
son, 1990). The sequence around the threonine at position
2255 most closely matches the consensus sequence of R(K)-
XXT(S)XR(K) . Computer searches have revealed no signi-
ficant homology between the NG2 cytoplasmic domain and
any other protein in the database. This indicates that NG2
may be a novel integral membrane proteoglycan.
The extracellular region of NG2 can be divided into three
domains: two cysteine-containing domains separated by a
serine-glycine-rich domain in the middle (Fig. 5, A and B) .
Fourteen potential N-linked glycosylation sites (NXS/T; Hub-
bard and Ivatt, 1981) are found throughout the extracellular
domain (Figs. 3 and 5, *). Biosynthetic pulse-chase experi-
ments utilizing tunicamycin, endoglycosidase H, and neur-
aminidase have suggested that NG2 is initially synthesized
as a MAD polypeptide (in good agreement with the calcu-
lated value of251 kD) which is glycosylated to yield the ma-
ture 300-kD core glycoprotein (Stallcup et al., 1983). How-
ever, we have no information at present concerning which of
the potential glycosylation sites are actually used.
The first domain (amino acids 30-640) contains eight cys-
teine residues. The relative positions ofthe cysteine residues
and the intervening amino acid sequences are different from
those found in EGF-like repeats (Doolittle et al ., 1984),
immunoglobulin-like repeats (Williams and Barclay, 1988),
or the link protein-like sequences (Neame et al., 1986) that
have been commonly identified in many large extracellular
and cell surface molecules. A short stretch of acidic amino
acids EEDEYEEE (residues 384-391) is found in this region
between the fourth and the fifth cysteines. A cluster ofhydro-
phobic amino acids is found between residues 424 and 440.
Following this cysteine-rich domain is a region consisting
of 950 amino acids (residues 641-1590), which is devoid of
cysteine residues but contains nine serine-glycine pairs. The
amino acid sequences around the serine residues at positions
998 and 1342 conform to the consensus sequences for chon-
droitin sulfate attachment sites proposed by Zimmermann
and Ruoslahti (1989; E/DGSGE/D) and Bourdon et al. (1987;
SGXG), respectively. Thus, this region can be putatively
defined as the glycosaminoglycan attachment domain.
The last extracellular domain consists of 634 amino acids
and contains eight cysteine residues, six of which are clus-
tered within a stretch of 35 amino acids near the transmem-
brane domain. A homology search through the database re-
sulted in the identification of a stretch of 15 amino acids
within this domain (residues 2050-2064) which has a 40%
identity with a segment near the carboxy terminus of the
a-subunit of humaninsulin receptor-related receptor (Shier
and Watt, 1989). In particular, the three cysteine residues
(CC-C) in this segment are conserved not only in these two
proteins, but also in insulin receptor and insulin-like growth
factor I receptor.
ImmunochemicalAnalysis ofProteolytic Fragments
ofNG2
To obtain biochemical information about the extracellular
domains of NG2 described in the previous section, proteo-
lytic products of 1251-labeled B49 cells were subjected to
immunoprecipitation analysis using antibodies against vari-
ous portions of NG2. Fig. 6 A shows that all four ofthe anti-
bodies used are able to immunoprecipitate the intact 300-kD
core protein of NG2 . As shown in Fig. 6 C, rabbit antibody
365
SFigure6 . Immunoprecipitation of fragments ofNG2 . All ofthe immunoprecipitates described below were analyzed by SDS-PAGE using
3-20% gradient gels . 0) low30û-kD core protein from detergent extract . (B) 200-kD fragment from EDTA supernatant . 1251-labeled
B49 cells were incubatedQ2 hat room temperature in Cal-Mg+'-free HEPES-buffered Eagles medium containing 10 mM EDTA and
0.2 U/tril chondroitinase ABCAM centrifugation to"0 the"the supernatant was adjusted to contain I% NP-40 and 0.5% SDS
and used for the inummoprecipitations shown in B . The cell pellet was extracted for 10 min with PBS containing 1% NP-40. Insoluble
material was removed by centrifugation, and the detergent extract was adjusted to contain 0.5% SDS before being used for the im-
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366Figure 7 . Internal repeats of NG2 . (top) Line at the top shows a scheme ofNG2 protein with the scale in amino acid residues . Shaded
area (TM) indicates the position of the transmembrane domain . Positions of the three types of repeated sequences are shown under the
scale . (middle) Alignmentoffour segments ofrepeatAandchickN-cadherin sequences. Gaps were allowed to maximizematches . Numbers
at the margins denote amino acid residue numbers . Residues occurring in at least two segments are shaded . Letters above the sequence
are conserved residues : capitalandsmall letters are residues conserved in all four segments ofNG2and three ofthe four segments, respec-
tively . Thedegrees ofsimilarity between each of the four segments ofNG2areshownon the right. The region of highest similarity between
N-cadherin and NG2 is found at the carboxy terminus ofthe second repeat ofN-cadherin . (bonom) Alignmentoftwosegments ofrepeatB.
against intact NG2 (4447) precipitates a 120-kD fragment
which is released from B49 cells by mild trypsinization . This
fragment canalso be immunoprecipitated by antibody 1088,
establishing that it contains theaminoterminus ofNG2. An-
tibodies against the cytoplasmic domain (1466) and against
the 55-kD CNBr fragment (1114) fail to recognize the 120-
kD peptide. Based on this immunochemical information and
on the size of the peptide, we can predict that this fragment
should contain the amino-terminal cysteine-rich domain of
NG2 (Fig . 5 C) . This fragment hasafaster mobility on SDS-
PAGE under nonreducing conditions than under reducing
conditions (Fig . 6D) . Moreover, the epitope within the frag-
ment which is recognized by mAb D31.10 is destroyed by
reduction with 2-mercaptoethanol (data not shown) . Both of
these findings suggest that at least some of the cysteines in
this domain participate in the formation of intramolecular
disulfidebondsthat stabilize the molecularconformation . In
addition, the 120-kD fragment appears on gels as a discrete
bandwhose mobility is notaffected by treatment with chon-
droitinase ABC (Fig . 6 D), suggesting that the three serine-
glycine pairs found at the beginning of the first domain are
not sites for the addition of chondroitin sulfate chains.
A 200-kD fragment of NG2, also reactive with antibody
4447, can be released from B49 cells by incubation with
EDTA in the presence of chondroitinase ABC (Fig . 6 B) .
This peptide is also recognized by the amino terminal 1088
antibody, but unlike the 120-kD fragment, can be immuno-
precipitated with the 1114 antibody against the 55-kD CNBr
fragment . The 1466 antibody against the cytoplasmic do-
main does not recognize the 200-kD fragment . These find-
ings indicate that this fragment begins at theaminoterminus
ofNG2 andextends into the region ofthe 55-kDCNBr frag-
munoprecipitations shown in A. N, antibody 1088 against NG2 aminoterminus . Np, 1088 preimmune . W, antibody 4447 against whole
NG2 . I, antibody 1114 against internal 55-kD CNBr fragment . Ip, 1114 preimmune. C, antibody 1466 against NG2 cytoplasmic domain .
Cp, 1466 preimmune . Wu, Same as W, but undigested with chondroitinaseABC. Sample wasprepared as above, except that chondroitinase
ABC was omitted during incubation with EDTA . (C) 120-kD fragment from trypsin supernatant. 1251-labeled B49 cells were incubated
for 30 min at room temperature in PBS containing 5 /.g/ml trypsin. Cells were pelleted, and tryptic activity was stopped by addition of
2% FCS, 1mM PMSF, and 0.1 mg/ml soybean trypsin inhibitor to the supernatant . The supernatant was adjusted to contain 1% NP-40
and 0.5% SDS and used for the immunoprecipitations shown in C . Symbols are as inA andB . (D) Mobility of 120 kD tryptic fragment .
Immunoprecipitates prepared from trypsin supernatants using antibody 4447 (W) as described in Cwere either left untreated (-) or were
digested overnight with0.02UofchondroitinaseABC(+). Portions ofthese samples were then subjected to reduction with 5% 2-mercapto-
ethanol (red) or were left nonreduced (non).
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367ment . Therefore, both the amino-terminal cysteine-rich do-
main and the serine-glycine-rich domain must be included
in this peptide (Fig . 5 C) . In the absence of chondroitinase
ABC, this fragment appears as a heterodisperse component
of -400 kD on SDS-polyacrylamide gels (Fig . 6 B), sug-
gesting that some of the serine-glycine pairs in the second
extracellular domain serve as acceptor sites for the attach-
ment of chondroitin sulfate chains .
Internal Repeats
A search for repeated amino acid sequences within NG2
resulted in the identification of four 200-amino acid-long
regions in the extracellular domain (Fig. 7, repeat A) . The
four repeats (1, 501-700 ; 11, 971-1,170 ; III, 1,431-1,630 ; IV,
1781-1980) are evenly spaced and span most of the extracel-
lular domain ofNG2, ending amino terminal to the last clus-
ter of cysteines . Regions of best alignment are shown in Fig .
7. The degree of identity between these repeats ranges from
19 to 26%, the highest being between repeats III and IV.
Negatively charged residues and glycines are well conserved
in all four repeats .
A homology search through the data base revealed a
similarity between a portion ofthese repeatedNG2 domains
and a portion ofthe repeats found in chick N-cadherin (Hatta
et al ., 1988) . Comparison ofNG2 and N-cadherin sequences
is shown in Fig . 7. The region of highest similarity between
the two proteins occurs in a 12-residue segment at the car-
boxy terminus of the second N-cadherin repeat . This partic-
ular segment of the cadherin repeats has been proposed to
be involved in Ca++-binding (Hatta et al ., 1988 ; Ringwald
et al., 1987), suggesting the possibility of a similar function
for this portion of the NG2 repeats . The algorithms of Gar-
nier (1978) andGGBSM (Gascuel and Golmard, 1988) pre-
dict that the conformation within each of these NG2 repeats
wouldbe composed of a ß-sheet structure followed by a ß-turn
or coil . Similar structures have been predicted for the corre-
sponding regions ofthe uvomorulin repeats (Ringwald et al .,
1987) .
A second type of repeat consisting of 30 amino acids is
found in the carboxy-terminal one-third of the extracellular
domain (residues 1,535-1,564 and 2,001-2,030, repeat B,
Fig. 7) . No comparable examples of this repeat were found
in other molecules .
A tripeptide FRV appears five times in the extracellular
domain ofNG2 (at positions 641, 702, 877, 1,011, and 1,576) .
All five are within the serine-glycine-rich domain, four clus-
tered in the amino-terminal half of this portion of the mol-
ecule .
Southern BlotAnalysis ofGenomicDNA
Southern blots ofrat genomic DNA digested with four differ-
ent restriction enzymes were hybridized with a 415-bp cDNA
probe encoding a proximal region of the extracellular do-
main (Fig. 2, 9P400) . As shown in Fig . 8, a single band was
detected in each of the four digests, indicating that NG2 is
encoded by a single gene .
Discussion
From four differentcDNA librarieswe have isolated overlap-
ping cDNA clones encoding the entire core protein of the
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Figure 8 . Southern blot of rat
genomic DNA . 10 ug of rat
genomic DNA were digested
with the restriction enzymes in-
dicated, run on a 0.7 % agarose
gel, blotted onto a nitrocellu-
lose filter, andhybridized with
a 32P-labeled 415-bp cDNA
probe encoding the carboxy-
terminal end of the extracellu-
lar domain ofNG2 . Molecular
weight standards are indicated
on the left . Single bands are
detected in all four digests .
large cell surface chondroitin sulfate proteoglycanNG2 . These
cDNA clones span 8,071 nucleotides and encode a protein
of 2,325 amino acids . Northern blot analysis using an NG2
cDNA probe demonstrates the presence of a single major
mRNA species of 8.9 kbp in rat neural cell lines . Southern
blot analysis of rat genomic DNA reveals unique bands in
all the restriction digests, suggesting that NG2 gene is pres-
ent as a single copy in the rat genome . The deduced amino
acid sequence of the NG2 core protein predicts an integral
membrane protein with a large extracellular domain and a
small cytoplasmic tail consisting of 76 amino acids .
Primary structures of several integral membrane proteo-
glycan core proteins, the prototype of which is syndecan,
have been reported (Saunders et al., 1989 ; Marynen et al.,
1990; and Kiefer et al ., 1990) . These sequences share a com-
mon cytoplasmic domain . The cytoplasmic domain of NG2
is larger and does not have any homology with thatofthe syn-
decan family ofproteoglycans . No sequence similarities were
detected with the sequences ofCD44 (Goldstein et al ., 1989),
thrombomodulin (Jackman et al ., 1986), and invariant chain
of the class II histocompatibility antigen (Strubin et al ., 1984),
which have all been shown to exist as membrane-spanning
proteoglycans (Fransson, 1987) . Therefore, NG2may be con-
sidered a novel species of integral membrane proteoglycan .
Within the transmembrane domain of NG2, there is onecysteine residue. A cysteine residue is also foundin the trans-
membrane domains of CD44 (Goldstein et al., 1989), syn-
decan (Saunders et al., 1989), and the FGF-binding pro-
teoglycan (Kiefer et al., 1990). Cysteine residues within the
transmembrane domain may be fatty acylated via a thioester
linkage as has been shown for the heavy chain of the major
histocompatibility complex antigens, HLAB and DR (Kauf-
man et al ., 1984), and myelin-associated glycoprotein
(Pedraza et al., 1990). At present, we have no evidence for
this type of linkage in the case of NG2 .
The cytoplasmic domain of NG2 contains three threo-
nine residues that may be potential sitesfor phosphorylation
by protein kinase C. Although it remains to be determined
whether NG2 is phosphorylated, this information along with
the organization of NG2 with respect to the plasma mem-
brane would be consistent with a model in which NG2 is in-
volved in signal transduction.
The extracellular domain ofNG2 can be divided into three
structural domains : an amino-terminal domain containing
eight cysteines, a second cysteine-free domain containing
serine-glycine pairs, and a third cysteine-rich domain. We
have provided two pieces ofevidence that the cysteines in the
first domain participate in forming disulfide bonds within the
domain. First, the 120-kD tryptic fragment that contains this
region has a higher mobility through an SDS polyacrylamide
gel under nonreducing conditions than under reducing con-
ditions. Second, the epitope on this fragment recognized by
mAb D31 .10 is destroyed by reduction. This tryptic fragment
appears to be free of chondroitin sulfate chains since its elec-
trophoretic mobility is unaltered by treatment with chon-
droitinase ABC. Thus, it can be postulated that the first do-
main consisting of the amino-terminal 611 residues of the
mature protein has a globular or compact configuration sta-
bilized by disulfides. A stretch of hydrophobic amino acids
found between residues 424 and 440 may lie inside this
folded structure.
A cluster of acidic residues is found within this globular
domain . A similar acidic sequence has also been found be-
tween the amino-terminal, link protein-like globular domain
and the glycosaminoglycan attachment domain of versican
(Zimmermann and Ruoslahti, 1989) and between the first
and second immunoglobulin-like repeats in the extracellular
domain ofbasic fibroblast growth factor receptor (Lee et al.,
1989). The occurrence of such a cluster of acidic residues
in the extracellular region is considered to be unusual and
its functional significance is not clear.
Following the amino terminal globular domain is a re-
gion that contains nine serine-glycine pairs. The proteolytic
fragment of NG2 which contains this region migrates as a
single sharp band of 200 kD when treated with chondroi-
tinase ABC, but is seen as a polydisperse component of
-400 kD in the absence of treatment with the enzyme, indi-
cating that at least some of the serine residues in this region
serve as chondroitin sulfate acceptor sites. Preliminary anal-
ysis of glycosaminoglycan chains released with alkali from
purified NG2 suggests that the size of the chains may be
nearly 100 kD (unpublished results). Based on the estima-
tion ofthe average size of intact NG2 as 600 kD and the core
protein size as 300 kD, it can be calculated that NG2 con-
tains two or three glycosaminoglycan chains. There are two
serine residues in NG2 whose surrounding sequences con-
form to the consensus sequences proposed for glycosamino-
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glycan attachment sites by Bourdon et al. (1987) and Zim-
mermann and Ruoslahti (1989) . However, little information
is available on the correlation of predicted and actual glycos-
aminoglycan attachment. Other factors such as secondary
structure might also be important in the recognition of at-
tachment sites (Krueger et al., 1990). Lacking in cysteine
residues, the second domain may take an extended confor-
mation, as hypothesized for the serine-glycine-rich domains
of other proteoglycans (Doege et al., 1987; Zimmermann
and Ruoslahti, 1989).
The third domain contains eight cysteine residues, six of
which are found in close proximity to one another. We have
no information as to whether these cysteines are involved in
disulfide bonding. It seems unlikely that these cysteines form
disulfide bonds with cysteines in the amino terminal domain,
since the 120-kD tryptic fragment is released from the cell
surface in the absence of reducing agents. However, disulfides
within the third domain or intermolecular disulfides remain
possibilities. Cysteine clusters that lie just outside the trans-
membrane domain have been implicated in the formation of
intermolecular disulfide bonds in other proteins such as the
Drosophila Notch protein (Kidd et al ., 1989). The cysteine
residues in insulin receptor-like receptor, whose positions
match those of cysteine residues 2050, 2051, and 2053 in
NG2, are thought to be involved in intersubunit disulfide
bond formation (Shier and Watt, 1989). NG2 appears to
form some higher molecular weight aggregates under nonre-
ducing conditions (data not shown), but more rigorous ex-
periments are needed to determine whether these are homo-
multimers. Intermolecular disulfide bonds have been shown
to occur in a cell surface heparan sulfate proteoglycan found
on endothelial cells (Hiss et al ., 1987).
The two cysteine-containing domains of NG2 do not have
any sequence similarities to the hyaluronic acid-binding do-
mains found in other proteoglycan core proteins (Doege et
al., 1987; Zimmermann and Ruoslahti, 1989; Goldstein et
al., 1989) or link protein (Neame et al ., 1986). NG2 is not
recognizedby the mAb 1C6 (Nishiyama et al ., 1991), which
recognizes an epitope within the hyaluronic acid-binding re-
gion of the cartilage proteoglycan (Caterson et al., 1986).
Therefore, NG2 does not seem to have a hyaluronic acid-
binding function, which distinguishes it from hyaluronic
acid-binding molecules found in the brain (Ripellino et al.,
1989; Perides et al ., 1989).
NG2 has been shown to bind to type VI collagen through
its core protein (Stallcup et al., 1990). Some coimmunopre-
cipitation of type VI collagen light chains (140 kD) can be
seen with both intact NG2 (Fig. 6 A) and the 200-kD frag-
ment of NG2 (Fig. 6 B). It may be noteworthy that type VI
collagen is not coimmunoprecipitated with the 120-kD tryp-
tic fragment (Fig. 6 C). This could indicate that the binding
site for type VI collagen lies outside the domain represented
by the smaller fragment and is found within the central por-
tion of the NG2 polypeptide. Construction of deletion mu-
tants should help define the region of NG2 core protein that
binds type VI collagen.
Three types of repeated sequences are found in the ex-
tracellular domain of NG2. Short segments consisting of 30
amino acids (repeat B) are found repeated twice. The sig-
nificance of this type of repeat is unclear. Nor is the sig-
nificance of five repeats of the tripeptide FRV clear. More
highly conserved repeats, consisting of 200 amino acids (re-
369peat A), are found four times, evenly spaced, in the extracel-
lular domain of NG2. A small region within repeat A shares
a significant degree of homology with the portion of the
cadherin repeats which has been proposed to be involved in
Ca++ binding (Hatta et al., 1988; Ringwald et al., 1987).
Although this region does not have the typical EF-hand
structure known to be present in many intracellular Ca++-
binding proteins (Kretsinger, 1980), the conservation of
negatively charged residues in each of the NG2 repeats sug-
gests the importance ofthese residues and their possible role
in Ca++ binding. Ca++ could be involved in stabilizing the
conformation ofNG2 itself. It is ofinterest in this regard that
treatment of B49 cells with EDTA causes the release of a
large portion of the NG2 ectodomain from the cell surface.
At present, we do not know the mechanism underlying this
process. One possibility is that treatment with EDTA acti-
vates a proteolytic activity that releases the fragment. How-
ever, it is also possible that proteolysis has already occurred
before the EDTA treatment, and that the resulting fragments
of NG2 are held together by Ca--dependent intramolecular
interactions. Chelation of Ca++ by EDTA would effect re-
lease of the large fragment. Ca++ may also be important in
cell adhesion, ligand binding, or other functions that occur
involving NG2 at the cell surface. Further insight into the
function of NG2 may be obtained from such experiments as
expressing intact and mutant NG2 in NG2-negative cells.
In conclusion, we have presented the complete cDNA se-
quence and the deduced amino acid sequence ofthe core pro-
tein of a large chondroitin sulfate proteoglycan, NG2 . The
primary structure predicts an integral membrane protein
with a large extracellular domain and a short cytoplasmic tail
that has no extensive homology with any known protein.
These results indicate that NG2 is a novel integral membrane
proteoglycan and suggest its role as a cell surface receptor.
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